日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Preclinical Evaluation of IMGC936, a Next-Generation Maytansinoid-based Antibody-drug Conjugate Targeting ADAM9-expressing Tumors

针对 ADAM9 表达肿瘤的下一代美登木素抗体药物偶联物 IMGC936 的临床前评估

Juniper A Scribner #, Stuart W Hicks #, Kerstin W Sinkevicius, Nicholas C Yoder, Gundo Diedrich, Jennifer G Brown, Jacquelynn Lucas, Megan E Fuller, Thomas Son, Anahita Dastur, Jeff Hooley, Christopher Espelin, Marian Themeles, Francine Z Chen, Ying Li, Michael Chiechi, Jenny Lee, Bhaswati Barat, Lu

Microscale screening of antibody libraries as maytansinoid antibody-drug conjugates

作为美登木素抗体-药物偶联物的抗体库的微尺度筛选

Kalli C Catcott, Molly A McShea, Carl Uli Bialucha, Kathy L Miller, Stuart W Hicks, Parmita Saxena, Thomas G Gesner, Mikias Woldegiorgis, Megan E Lewis, Chen Bai, Michael S Fleming, Seth A Ettenberg, Hans K Erickson, Nicholas C Yoder

Non-viral adeno-associated virus-based platform for stable expression of antibody combination therapeutics

基于非病毒腺相关病毒的抗体联合疗法稳定表达平台

Gwendolyn M Wilmes, Kimberly L Carey, Stuart W Hicks, Hugh H Russell, Jesse A Stevenson, Paulina Kocjan, Stephen R Lutz, Rachel S Quesenberry, Sergey V Shulga-Morskoy, Megan E Lewis, Ethan Clark, Violetta Medik, Anthony B Cooper, Elizabeth E Reczek